Covered recipient · General Payments record
JENNIFER ELROD KNAPP
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$923.42
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $404.60 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $90.88 | 1 |
| ABBVIE INC. | $71.48 | 3 |
| Novo Nordisk AS | $63.17 | 4 |
| GlaxoSmithKline, LLC. | $54.54 | 3 |
| Lilly USA, LLC | $44.96 | 3 |
| Nevro Corp. | $26.95 | 1 |
| Daiichi Sankyo Inc. | $24.69 | 1 |
| Amgen Inc. | $14.13 | 1 |
| Esperion Therapeutics, Inc. | $13.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.06 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107474048 | CMS |
| ABBVIE INC. | $29.01 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107474050 | CMS |
| ABBVIE INC. | $19.41 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107474052 | CMS |
| Amgen Inc. | $14.13 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115820300 | CMS |
| AstraZeneca Pharmaceuticals LP | $90.88 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104707397 | CMS |
| Daiichi Sankyo Inc. | $24.69 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089443479 | CMS |
| Esperion Therapeutics, Inc. | $13.80 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129470316 | CMS |
| GlaxoSmithKline, LLC. | $17.84 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116580867 | CMS |
| GlaxoSmithKline, LLC. | $19.82 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116494766 | CMS |
| GlaxoSmithKline, LLC. | $16.88 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116448903 | CMS |
| Lilly USA, LLC | $13.91 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135682427 | CMS |
| Lilly USA, LLC | $14.98 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135656033 | CMS |
| Lilly USA, LLC | $16.07 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135702287 | CMS |
| Nevro Corp. | $26.95 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130775551 | CMS |
| Novo Nordisk Inc | $14.44 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100385619 | CMS |
| Novo Nordisk Inc | $17.29 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100270923 | CMS |
| Novo Nordisk Inc | $15.96 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100294358 | CMS |
| Novo Nordisk Inc | $15.48 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100516963 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.